China has spent the past two decades building manufacturing capacity, subsidizing scale, automating factories, securing raw materials and investing heavily in research.
According to a report from Reuters, the deal is backed by venture capital firms Matter Venture Partners, Kleiner Perkins, Spark Capital, Exor and GV, previously called Google Ventures.
Shares of network testing solutions company Viavi Solutions (NASDAQ:VIAV) jumped 14.3% in the afternoon session after the company reported strong fourth-quarter 2025 results that beat expectations and provided an optimistic forecast for the upcoming quarter.
Shares of aerospace and defense company Hexcel (NYSE:HXL)
jumped 7.4% in the afternoon session after its fourth-quarter results beat Wall Street's expectations, overshadowing a weaker-than-anticipated forecast for the full year.
Shares of chip designer Allegro MicroSystems (NASDAQ:ALGM) jumped 8.1% in the afternoon session after the company reported fourth-quarter 2025 results that featured a notable revenue beat and a robust outlook for the upcoming quarter.
Shares of government engineering solutions provider Amentum Holdings (NYSE:AMTM) jumped 3.4% in the afternoon session after the company announced multiple significant contract wins related to nuclear energy and received positive analyst commentary.
Shares of CRM software giant Salesforce (NYSE:CRM) fell 7.2% in the afternoon session after negative sentiment spread across the software sector as peers including Microsoft (MSFT), SAP (SAP), and ServiceNow (NOW) provided mixed updates.
Shares of industrial conglomerate Honeywell (NASDAQ:HON)
jumped 4.6% in the afternoon session after the company reported mixed fourth-quarter 2025 results that featured a profit beat but a revenue miss.
Shares of electronic component provider Littelfuse (NASDAQ:LFUS) jumped 3.3% in the afternoon session after the company reported fourth-quarter results that beat analyst expectations and provided a strong forecast for the upcoming quarter, leading to an analyst upgrade.
Shares of technology and consulting giant IBM (NYSE:IBM) jumped 3.6% in the afternoon session after the company reported fourth-quarter results that beat Wall Street estimates and offered a strong financial outlook for the upcoming year. The technology and consulting giant's revenue grew 12.1% year-over-year to $19.69 billion, while its adjusted earnings of $4.52 per share also topped expectations. The company's performance was lifted by its Software segment, which has consistently outperformed its total sales. Looking ahead, IBM projected constant currency revenue growth of more than 5% for 2026 and an increase of about $1 billion in year-over-year free cash flow, signaling confidence in its future performance. The positive results and upbeat guidance were well-received by investors.
Shares of luxury cruise operator Viking (NYSE:VIK) jumped 4.8% in the afternoon session after positive results from rival Royal Caribbean suggested strong demand across the cruise industry.
Shares of homebuilding company PulteGroup (NYSE:PHM) jumped 3.5% in the afternoon session after the company reported mixed fourth-quarter results, where a strong revenue beat appeared to outweigh an earnings shortfall.
The company said on Tuesday that it intends to file an application in the second half of 2026 to begin its first in-human trial for its new development candidate KRRO-121.
Regional banking company Origin Bancorp (NYSE:OBK) reported revenue ahead of Wall Streets expectations in Q4 CY2025, with sales up 14.5% year on year to $102.9 million. Its non-GAAP profit of $0.99 per share was 15.3% above analysts’ consensus estimates.
Norwegian Cruise Line shares are climbing as investors extrapolate Royal Caribbean's upbeat earnings and booking trends to the broader cruise industry.
Usually placid and steadily rising, gold is now skyrocketing like bitcoin in the midst of a bull run, while the digital currency is enjoying a year of calm and stability.
Eli Lilly signs major deals with Repertoire Immune and Seamless Therapeutics, committing billions to autoimmune disease treatments and gene therapies targeting hearing loss.
